- Sort by Popularity (sales)
- Display 15 Products per page
Published: October 1, 2008 | Price: $7,995.00 – $14,995.00
According to Kalorama's experts, there is over a 40 billion dollar market for technology companies who can assist the healthcare industry meet its key challenges. This Kalorama Information Market Research Bundle, a combination of 7 Kalorama Information Market research reports - over 1200 pages of material., presents those opportunities, and details the areas Kalorama thinks will be the most promising markets for technology in healthcare. Wireless Technologies: Newly updated with forecasts for 2008-12. This report covers the technology that is...Published: October 1, 2008 | Price: $9,995.00 – $19,990.00
Kalorama Information has been watching medical device markets in 2008 and has produced several market research studies useful to companies operating in this market. To maximize market research dollars, we've assembled one PDF that contains eight critical research studies with market forecasts, product reviews, company profiles and other information regarding these markets The following medical device topics, representing 1,500 pages of information, are detailed in this bundle. Infusion Pumps (includes Ambulatory, Disposable, Syringe and Special Pumps) Catheter Markets (Urological, Intravenous,...Published: October 1, 2008 | Price: $3,500.00 – $7,000.00
Driven by mounting market pressures, companies are increasingly implementing outsourcing strategies to increase revenues through faster drug development. By decreasing their in-house facilities and staff, and outsourcing more of their R&D functions, pharmaceutical and biotechnology companies are reshaping the drug development services industry. Kalorama Information's Outsourcing in Drug Development is the third edition of this study of the drivers for outsourcing drug development, the companies involved in this market and the opportunity for revenues. Part of the CMO Market Series,...Published: October 1, 2008 | Price: $2,995.00 – $6,995.00
The strategic concept of HIV/AIDS diagnosis and therapy is one of the most complex that the healthcare industry has ever seen. In order to cope with the challenges and opportunities of HIV/AIDS diagnostics and therapeutics, companies must think on a global basis. In addition to the basic pathology and complications of HIV/AIDS, there are primarily three focal points for the development of strategy in this area: potential market, epidemiology (HIV/AIDS patient trends) and technology. In his report HIV Markets for...Published: September 1, 2008 | Price: $2,250.00 – $5,500.00
Contract Manufacturers seeking to partner with global marketers can find the best opportunities making the medical devices that drive the best sales and growth for global marketers. This report covers contract manufacturing (CM) in several medical devices that show promising growth for the next five years. The report details the following areas and provides forecasts for the next five years: Cardiac Pace Makers Implantable Defibrillators Catheters Syringes Orthopedic Hip Implants Orthopedic Knee Implants Oxygen Concentrators (Standard and Portable) Continuous...Published: September 1, 2008 | Price: $1,500.00 – $6,995.00
Infusion pumps are used to infuse necessary fluids, which includes medications and/or nutrients, to a patient’s circulatory system. Infusion pumps are often used in situations where continuous monitoring and treatment by a nurse or other health staff would be expensive, impractical, or unreliable. For the purpose of this study, we have classified two general types of infusion pumps: General Purpose Infusion Pumps Specialty Infusion Pumps General purpose infusion pumps are used in a variety of applications and settings from basic...Published: September 1, 2008 | Price: $3,500.00 – $7,000.00
Minimally invasive surgery (MIS) allows doctors to perform many complicated operations with a short hospital stay. It is a safe, feasible, and patient-friendly method of performing an operation. The report includes product information, procedure volume data, world demographics; and other general issues affecting the MIS device market. Information is presented as a worldwide overview, with a focus on the US. A market summary includes market analysis by intended use and a competitive analysis of leading providers. Additionally key company profiles...Published: August 1, 2008 | Price: $2,995.00 – $5,000.00
A perfect supplemental information resource for customers who have already purchased The Worldwide Market for In Vitro Diagnostic Tests, 6th Edition, The IVD Market Research Supplement bundle studies and quantifies in greater detail some of the important areas that will have a transforming impact on the diagnostic industry: • Companies are now performing diagnostic tests as a service rather than simply selling kit to laboratories. Are companies seeking profit, or a 'back-door' around FDA regulations? And does it have growth...Published: August 1, 2008 | Price: $1,500.00 – $7,000.00
Test services, once the norm in the diagnostics industry, then abandoned for reagent sales, are now making a comeback. IVD companies have established cGMP and CLIA-registered labs by which they offer their proprietary tests to physicians, hospitals and reference labs. These tests are outside the oversight of the traditional FDA and CE Mark test commercialization avenue in the U.S, and Europe and so are thought to come to market by what may seem to be the back door. Kalorama has...Published: August 1, 2008 | Price: $2,995.00 – $5,990.00
The market for respiratory disposables and reusable accessories is witnessing dynamic changes. The market factors influencing demand in the U.S. are also present in Europe and the Asia/Pacific region — the aging of the population, technological trends and society’s acceptance of people with disabilities. Kalorama's World Market for Respiratory Equipment and Disposables represents the third time that Kalorama Information has tackled this important device market. This report analyzes the worldwide market for respiratory disposables and reusables, including the following segments:...Published: August 1, 2008 | Price: $1,500.00 – $7,000.00
The benefits of automation in the clinical laboratory are well documented. They involve replacing manual, potentially dangerous, error-prone steps with automated processes requiring minimal operator intervention. This approach can increase productivity, decrease turnaround time, improve staff safety, minimize errors, improve the handling of specimens, and allow labs to reallocate personnel to more important and productive tasks. For drug discovery, automation also offers benefits. bringing a new drug to market has been both a very time-intensive, laborious and expensive undertaking. This...Published: August 1, 2008 | Price: $1,500.00 – $4,995.00
Alzheimer’s Disease is the most common cause of dementia, constituting 60% to 70% of all cases, and the risk with the disease doubles every 5 years after age 65. Incidence of the disease is increasing, and the resulting attention given to Alzheimer's Disease has encouraged development of new treatments. There is an opportunity for pharmaceutical companies to compete in this market, as Kalorama analyst Melissa Elder outlines in this study. This report includes incidence of Alzheimer’s disease worldwide with information...Published: August 1, 2008 | Price: $3,500.00 – $7,000.00
The aging of the population, namely the baby boomer demographic segment is driving the market for facial rejuvenation products. The size and wealth of this aging segment and its overwhelming desire to retain a youthful appearance are driving growth for aesthetic procedures. Worldwide, billions of dollars are spent annually on facial rejuvenation products and services. This report, Facial Rejuvenation Markets Worldwide from Kalorama Information, covers both products and services in this market. For this report, products pertain to: Topical Rejuvenation...Published: July 1, 2008 | Price: $3,995.00 – $7,990.00
As Kalorama publishes its second edition of this detailed report on the long term care industry and all of its segments, there is no decrease in demand or activity for everything from nursing homes, to home care, to hospices. The U.S. long care industry has experienced strong growth from 2002 through 2007 and this growth is expected to accelerate through the forecast period as the U.S. population continues to age and demand rises for long term care. Ongoing cost containment...Published: July 1, 2008 | Price: $500.00 – $7,000.00
Pharmaceutical markets in Brazil, Russia, India and China rank among the top twenty markets in the world with the potential to move up in ranking rather quickly. (China’s pharmaceutical market, for instance, is expected to show double-digit growth over the next five years.) Developing regions and petro-rich nations will be an integral part of expansion for companies looking to capture a larger portion of the worldwide market. Kalorama's Pharmaceutical Markets in Brazil, Russia, India and China (BRIC nations) takes a...